|
|
||||||||



,1
* Department of Animal Science, Ferdowsi University, Mashhad 91775-1163, Iran
Department of Clinical Sciences, and
Department of Animal Science, Cornell University, Ithaca, NY 14853
1 Corresponding author: wrb2{at}cornell.edu
| ABSTRACT |
|---|
|
|
|---|
(measured as 13, 14-dihydro-15-keto PGF2
; PGFM). Uterine endometrial biopsies were collected for fatty acid analysis and cyclooxygenase-2 (COX-2) protein measurement. Ovarian follicular activities as well as plasma estradiol and progesterone concentrations were similar across diets. Endometrial fatty acid composition of eicosapentaenoic acid (C20:5, n-3) and docosahexaenoic acid (C22:6, n-3) were increased as much as 3-fold by supplementation with fish meal and CaFOFA. Conjugated linoleic acid (C18:2 cis-9, trans-11) in the endometrium was also increased; conversely, arachidonic acid (C20:4, n-6) percentage was decreased by 5% FM. Plasma PGFM response to oxytocin injection was not different among diets and endometrial COX-2 protein abundance did not differ. Results from this experiment demonstrate that dietary supplementation with fish meal or n-3 fatty acids in early lactating dairy cows significantly increased uterine n-3 fatty acid concentrations, but had no apparent effect on endometrial COX-2 or PGF2
production in response to oxytocin challenge.
Key Words: cow fish meal cyclooxygenase-2 protein n-3 fatty acids
| INTRODUCTION |
|---|
|
|
|---|
and PGE2. Bovine endometrium secretes PGF2
during the estrous cycle (Danet-Desnoyers et al., 1995) and pulsatile secretion seems to mediate CL regression (McCracken et al., 1999). Expression of COX-2 mRNA and protein were found to be at low and high levels on d 1 to 12 and 13 to 21 of the estrous cycle, respectively (Arosh et al., 2002). Polyunsaturated fatty acids such as linoleic, linolenic, eicosapentaenoic (EPA), and docosahexaenoic (DHA) may inhibit uterine PGF2
synthesis through mechanisms such as decreased availability of the precursor ARA, increased competition by these fatty acids with ARA for binding to PGH synthase, and inhibition of PGH synthase synthesis or activity (Mattos et al., 2000). In vitro studies showed that the n-3 fatty acids EPA and DHA altered prostaglandin biosynthesis in a number of cells and tissues (Weber and Sellmayer, 1991; Mattos et al., 2003). The most potent COX-2 inhibitor was EPA followed by DHA (Ringbom et al., 2001). In another study, isomers of conjugated linoleic acid (CLA) also inhibited PGF2
synthesis and the effect was independent of the concentration of linolenic acid and n-6:n-3 ratio (Harris et al., 2001).
Fish meal (FM) has relatively large concentrations of 2 polyunsaturated fatty acids, EPA (C20:5, n-3) and DHA (C22:6, n-3) and so FM or fish oil fatty acids in the diet may alter uterine PGF2
synthesis. Inhibiting uterine secretion of PGF2
by feeding EPA and DHA may delay regression of the CL and increase fertility by improving embryo survival (Burke et al., 1997; Staples et al., 1998; Mattos et al., 2000).
Evidence for the incorporation of DHA (Mattos et al., 2004) and EPA (Burns et al., 2003; Mattos et al., 2004) into uterine lipids by feeding FM to cows has been reported. On the other hand, results from adding FM to the diet to reduce endometrial PGF2
production are inconsistent. Mattos et al. (2002) showed that feeding FM to lactating cows reduced secretion of PGF2
, whereas Wamsley et al. (2005) observed that FM supplementation had no effect on the secretion of PGF2
in nonlactating heifers having normal progesterone concentrations and only decreased PGF2
in those having reduced progesterone. In tissue cultures, net inhibition of endometrial PGF2
biosynthesis by n-3 fatty acids seems to vary depending upon the ratio of n-6 to n-3 fatty acids (Caldari-Torres et al., 2006).
The objective of the current study was to determine the effects of dietary supplementation with FM or specific n-3 fatty acids from fish oil on ovarian follicular activity and PGF2
production by the uterus in early lactating cows approaching the breeding period.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
|
Monitoring Ovarian Follicular Activity
Ultrasound measurements of follicular activity were made on alternate days from d 10 to 23 to ascertain the characteristics and fate of the first follicular wave, using a 7.5-MHz rectal transducer (Aloka 210; Corometrics Medical System Inc., Wallingford, CT). Dominant follicle development was characterized by follicular mapping of recorded ultrasound images (Beam and Butler, 1997). Follicular recruitment during the first follicular wave after parturition was evaluated by quantification of the numbers of 5- to 10-mm follicles on d 10 and 14 (Robinson et al., 2002). A dominant follicle was defined as a follicle that was >10 mm in diameter in the absence of other large (>9 mm) growing follicles. All ovulations detected by ultrasound were confirmed by analysis of plasma progesterone.
Synchronization of the Estrous Cycle
Cows were synchronized for ovulation beginning on d 23 with injection (i.m.) of 100 µg of GnRH (Cystorelin; Merial Ltd., Athens, GA) followed in 7 d with 30 mg of PGF2
(Lutalyse; Pfizer, New York, NY), followed in 48 h by a second injection of GnRH (d 0 of synchronized cycle). An intravaginal insert delivering progesterone (CIDR; InterAg, Hamilton, NZ) was inserted during the 7 d between the first injection of GnRH and PGF2
to better ensure ovulation in each lactating cow (Yavas et al., 1999).
Monitoring Uterine Conditions
On d 15 of the synchronized estrous cycle (49.3 ± 2.4 DIM), cows were injected intravenously at 1300 h with 100 IU of oxytocin (Butler Co., Columbus, OH). Using indwelling jugular catheters placed the day before, blood samples were collected at 15-min intervals from 1 h before until 3 h after the oxytocin injection and at 30-min intervals from 3 to 4 h postinjection to monitor uterine secretion of PGF2
. Plasma concentration of 13,14-dihydro-15-keto PGF2
(PGFM), a product of PGF2
metabolism, was assayed by using a RIA procedure described previously (Meyer et al., 1995).
Uterine endometrial biopsies were collected immediately after completion of the oxytocin challenge and blood sampling sequence by passing a biopsy tool through the cervix and into the uterine horn ipsilateral to the CL by using transrectal manipulation. No previous manipulation of the uterus had occurred before biopsy. The open jaws of the biopsy basket (2 x 1 mm) were pressed against the endometrium and samples (approximately 100 mg) of endometrium were removed. Uterine samples were washed with PBS (0.05 M NaPO4, pH 7.2), plunged into liquid nitrogen, and stored at 80°C.
Liver Tissue Biopsy
To confirm absorption of dietary fatty acids and availability to the body tissues, liver biopsy samples were collected on d 21 as previously described (Butler et al., 2003). The liver samples were washed with PBS and blotted dry, plunged into liquid nitrogen, and stored at 80°C.
Fatty Acid Analysis
Total fat content of the TMR was extracted using ether (Foss Tecator Soxtec System, Foss North America, Eden Prairie, MN; application subnote AN 3414; Dairy One Cooperative Inc., Ithaca, NY). Uterine and liver tissues were homogenized and lipids were extracted by the procedure of Hara and Radin (1978) by using a mixture of hexane and isopropanol. Following extraction, fatty acids in the samples were methylated (Chouinard et al., 1999) and methyl esters were analyzed by gas chromatography (GCD system HP 6890+; Hewlett Packard, Avondale, PA) equipped with a CP-Sil 88 capillary column [100 m x 0.25 mm (internal diameter) with 0.2-µm film thickness; Varian, Walnut Creek, CA]. A programmed temperature run was used: the oven temperature was initially maintained at 70°C for 2 min, then increased at 8°C/min to 110°C, and held for 4 min. The temperature was then increased at 5°C/ min to 170°C and held for 10 min. Finally it was increased at 4°C/min to 225°C and held for 15 min. Injector and detector temperatures were maintained at 250°C. The split ratio was 100:1, and hydrogen was used as the carrier gas at 2.1 mL/min. Fatty acid methyl ester standards were used to identify each compound in samples.
Western Blot
Western blots were used for quantifying the COX-2 protein. Endometrial biopsy samples were minced using a surgical blade and thoroughly homogenized in radioimmunoprecipitation buffer (40 mM Tris-HCl, 274 mM NaCl, 20% glycerol, 2% Nonidet P-40, 0.2% SDS, 1% Na-deoxycholate, 1 mM EDTA, pH 8) using a pellet pestle. Just before lysis, the following protease inhibitors were added: 25 mM ß-glycerophosphate, 5 mM benzamidine, 200 µM phenylmethylsulfonyl fluoride, 1 µM leupeptin, and 1 µM pepstatin (Sigma Chemical, St. Louis, MO). Lysates were cleared by centrifugation (1,500 x g, 10 min, 4°C). Total protein in the resulting cleared lysate was quantified (BioRad DC Protein Assay, BioRad Laboratories Inc., Hercules, CA). Proteins were denatured in loading buffer (40% SDS, 10% 1M Tris, 20% glycerol, 0.013% bromophenol blue) at 95°C for 3 min. Approximately 30 µg of total protein was loaded in each lane and electrophoresed on 6% SDS polyacrylamide gels (SDS-PAGE) at 150 V. Prestained protein markers (BioRad Precision Plus Protein Standards All Blue, BioRad Laboratories Inc.) were loaded as molecular weight standards onto each gel. The separated proteins were then transferred onto Polyscreen PVDF transfer membranes (PerkinElmer, Wellesley, MA) by transfer tank (Hoefer Scientific Instruments, San Francisco, CA) at 200 mA and 4°C. Proteins were blocked at 4°C with blocking buffer [1% NDM powder and 1% BSA in TBST buffer (10 mM Tris-HCl, 150 mM NaCl, 0.5% Tween-20, pH 7.6)]. The blots were incubated with primary antibody (Polyclonal Rabbit AntiHuman PGHS-2; Oxford Biomedical Research Inc., Oxford, MI) overnight at a dilution of 1:1,000 in the blocking buffer. Blots were washed 3 times at 10-min intervals in TBST and then incubated with secondary antibody (Goat AntiRabbit IgG Horseradish Peroxidase Conjugate; BioRad Laboratories) for 2 h at room temperature at a dilution of 1:5,000 in the blocking buffer. Then, blots were washed 4 times for 15 min each in TBST and chemiluminescence reagent containing luminol (PerkinElmer) was applied. Blots were exposed to Kodak X-OMAT Blue autoradiography film (Rochester, NY), the signal intensity was quantified by ImageJ 1.29x (Wayne Rasband, National Institutes of Health, Bethesda, MD), and expressed in arbitrary units.
Statistical Analyses
Data that were repeated in time were analyzed by using a mixed model (PROC MIXED, SAS Institute Inc., Cary, NC) for a completely randomized design with repeated measures using the following model:
![]() |
where Yijk = dependent variable, µ = overall mean, Ti = treatment effects, A(i)j = random effects of animal within treatments, Dk = effects of sampling date or time, (T x D)ik = interaction effects of treatment and sampling date or time, and
ik = residual error associated with the ijk observation.
Overall effect of treatment was tested using cow within treatment as the error term. Means were separated by Tukey-Kramer multiple range tests. Because of the requisite facilitative effect of plasma progesterone concentration on endometrial PGF2
production (Wamsley et al., 2005), PGFM data were also analyzed using plasma progesterone concentration on the day of oxytocin challenge as covariate. Three cows without a functional CL on d 15 of the synchronized cycle were removed from all PGFM and COX-2 analyses.
Data that were not repeated in time were analyzed by using a generalized linear model (PROC GLM, SAS Inst. Inc.) for a completely randomized design using the following model:
![]() |
where Yij = the dependent variable, µ = overall mean, Ti = treatment effects, and
ij = residual error.
Means were separated by Duncan multiple range test. Area under the curve (AUC) for PGFM was calculated using the statistical software package, NCSS 2000 (NCSS, Kaysville, UT). One cow fed the 5% FM diet required treatment for ketosis from d 10 to 40 of lactation and was subsequently dropped from all analyses and the study.
| RESULTS |
|---|
|
|
|---|
10 mm in diameter did not differ among diets. Follicle size on the day preceding synchronized ovulation (day of second GnRH) also was not affected by diet (14.9 ± 0.8 mm, mean ± SE). Only 5 cows (2, 1, and 2 cows fed control, 1.25% FM, and CaFOFA diets, respectively) ovulated a first-wave follicle before 23 DIM.
|
In liver, concentration of DHA and CLA (C18:2, cis-9, trans-11) was affected (P < 0.05) by diet. Concentration of DHA was greatest for cows fed 5% FM, whereas CLA was greatest in cows on the CaFOFA diet (Table 4
). Liver content of ARA (C20:4) was similar among diets (Table 4
), as were concentrations of linoleic (C18:2, cis-9, cis-12) and linolenic acids (C18:3).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
secretion and endometrial COX-2 protein. The incorporation of EPA, DHA, and ARA into endometrium tissue lipids in the present study are consistent with another study (Burns et al., 2003) that showed significant changes in fatty acid composition in caruncular tissue of cows fed FM in comparison with corn gluten meal. Furthermore, we found a significant effect of diet on increased total n-3 uterine fatty acids. Mattos et al. (2004) also reported an increase of EPA and DHA in caruncular tissue collected within 12 h after parturition in cows that had been fed a fish oil supplement. But, in contrast to their results, we also found an increase in CLA content of uterine fatty acids when tissues were collected at 49 DIM. The increase in CLA is not unexpected because a number of studies have shown that dietary supplements of FM or fish oil increase rumen production of cis-9, trans-11 CLA and its precursor, vaccenic acid (Bauman et al., 2003). It has been suggested that polyunsaturated fatty acids such as linoleic acid, linolenic acid, EPA, and DHA may inhibit uterine PGF2
synthesis through mechanisms such as decreased availability of the precursor ARA; increased competition by these fatty acids with ARA for binding has been shown that CLA inhibits PGF2
synthesis in rat uterine tissue independently of linolenic acid and n-6:n-3 ratio (Harris et al., 2001). Results of the present study demonstrated increased availability of n-3 fatty acids and incorporation of EPA, DHA, and CLA into endometrium, but these changes had no significant effect on PGF2
production in response to oxytocin. This was especially apparent for cows fed the 5% FM diet that had both the greatest uterine content of n-3 fatty acids and decreased ARA, the immediate precursor of PGF2
.
Endometrial COX-2 protein abundance was similar among diet treatments. Arosh et al. (2002) demonstrated that during the bovine estrous cycle, COX-2 was expressed throughout the cycle with maximal expression from d 16 to 18. A recent study shows that most, if not all, prostaglandin production in endometrial tissue is probably processed through COX-2 (Parent et al., 2003) and reduction of PGH2 to PGF2
is by 20
-hydroxysteroid dehydrogenase (Madore et al., 2003). In the present study, dietary supplementation with FM or CaFOFA resulted in increased endometrial content of EPA, DHA, and CLA, but no difference among diets for COX-2 protein. Endometrial biopsies for COX-2 were collected after the oxytocin challenge, but without other manipulation of the uterus. Our results are consistent with those of Mattos et al. (2004) showing that concentration of COX-2 protein in caruncular tissue was similar in cows fed fish oil compared with those fed olive oil. In addition, in vitro incubation of bovine endometrial cells for 24 h with EPA, DHA, or ARA did not affect the concentration of COX-2 and phospholipase A2 protein, but EPA inhibited PGF2
secretion (Mattos et al., 2003).
Previous results from feeding FM and fish oil to increase EPA and DHA and effects on PGF2
synthesis in dairy cows have been inconsistent. In one study, concentrations of PGFM in plasma were increased for lactating cows receiving formaldehyde-treated linseed oil and fish oil (Petit et al., 2002). In another study, nonlactating heifers were fed FM and no effect was detected in the PGFM response to oxytocin in heifers having a normal luteal progesterone profile and a decreased response only in those with reduced progesterone (Wamsley et al., 2005). On the other hand, results of other studies showed significant inhibitory effects of FM or fish oil on PGFM concentrations (Thatcher et al., 1997; Mattos et al., 2002, 2004). Although our current study used the same range of dietary FM supplementation shown to be inhibitory to PGF2
release in previous studies (Thatcher et al., 1997; Mattos et al., 2002), the PGFM response and AUC were not different from control (Figure 1
). Compared with a previous study in lactating cows (Mattos et al., 2002), we performed the oxytocin challenge after cows had received FM supplementation for a similar length of time (about 55 vs. 45 d, respectively), but much earlier in lactation (d 160 to 180 vs. d 50, respectively). Whether such differences in stage of lactation have an effect on uterine response to oxytocin has not been determined.
One difference among studies with regard to the effect of FM on PGFM response is whether estradiol was injected before the oxytocin challenge. Estradiol does not seem to change COX-2 expression directly, but rather it can up-regulate the oxytocin receptor, thereby increasing PGF2
release (Goff, 2004). Among studies feeding FM, PGFM was attenuated by increased n-3 fatty acids when estradiol injection was included (Mattos et al., 2002), but not when estradiol was omitted (Wamsley et al., 2005; results of the current study). Effect of inclusion of estradiol or not before oxytocin challenge was recently compared in lactating cows and the PGFM response was not different (E. Castaneda-Gutierrez and W. R. Butler, Cornell, Univ., unpublished observation). This indicates that differences between studies for effect of FM on PGFM response are not accounted for by whether estradiol was used in conjunction with the oxytocin challenge.
Another reason for divergent results in previous studies might be related to different amounts of individual dietary fatty acids besides EPA and DHA that were available for absorption from the gut and transport for uptake by the uterine endometrium. Dietary supplementation with a mixture of fatty acids (palmitic, stearic, oleic, and linoleic acids) would be expected to provide predominantly saturated fatty acids for absorption and resulted in increased plasma PGFM following an oxytocin challenge in lactating dairy cows (Fahey et al., 2002) and beef heifers (Filley et al., 2000). As for unsaturated fatty acids, dietary supplementation with linolenic acid (18:3 n-3) had no significant effects on PGFM concentrations compared with other diets (Petit et al., 2002, 2004; Robinson et al., 2002), whereas supplements containing linoleic acid (18:2 n-6) increased plasma PGFM concentrations (Robinson et al., 2002; Petit et al., 2004). Fahey et al. (2002) suggested that different results among studies might be explained by the fact that linoleic acid can act both as substrate and inhibitor of PGF2
synthesis. Consistent with this conclusion, the dose-response pattern with increasing intake of FM and decreasing response of PGFM to oxytocin injection was nonlinear (Mattos et al., 2002). In that study, dietary linoleic acid decreased as FM supplementation increased, but in our current study, the diets were balanced and content of linoleic acid across diets was not different.
Based on the results from a number of studies, it seems possible that shifts in the n-6:n-3 ratio in uterine tissue may be the basis for any inhibitory effects and net regulation of PGF2
secretion. Differential effects of changing the n-6:n-3 fatty acid ratio in bovine endometrial cell cultures was reported recently (Caldari-Torres et al., 2006). Secretion of PGF2
was markedly inhibited by preexposure of cells to EPA, but this inhibition was reversed when the endometrial cells were treated with an increasing n-6:n-3 ratio (linoleic:EPA ratio). The results did not further resolve the interacting mechanisms by which fatty acids affect PGF2
secretion in the bovine endometrium, but the authors suggested that the net inhibition of PGF2
synthesis by n-3 fatty acids may depend on the amount of n-6 fatty acids reaching the target tissue. In our study, dietary n-3 fatty acid supplementation decreased the n-6:n-3 ratio in the endometrium similar to that rendering marked inhibition of PGF2
secretion in the endometrial cultures (Caldari-Torres et al., 2006). Because uterine tissue fatty acid ratio cannot be readily predicted from diet composition because of extensive biohydrogenation and conversion in the rumen (Bauman and Griinari, 2003), regulation of PGF2
by altering dietary fatty acid composition in cows remains elusive.
Previous studies have demonstrated that dietary fatty acids can lead to stimulation of ovarian follicle activity (Lucy et al., 1991; Abayasekara and Wathes, 1999). In the present study dietary fatty acid supplementation had no effect on the size of the preovulatory follicle (day of second GnRH) and is consistent with another report (Robinson et al., 2002). The number of 5- to 10-mm ovarian follicles, however, was affected by diet; on d 10, cows fed the 5% FM diet had more follicles than those on the other diets.
Because the diets in the present study were formulated to contain similar amounts of lipid, increasing FM and CaFOFA in the present study did not increase the lipid content of the diet and so cholesterol concentrations linked to fatty acid absorption from the gut were similar among diets. Diet had no effect on progesterone and 17ß-estradiol concentrations in this study. We did not find any relationship between plasma progesterone concentration on the day of oxytocin challenge and the PGFM response in cows having a functional CL, in contrast to another recent study using beef heifers (Wamsley et al., 2005). We did observe near absence of the PGFM response for the 3 cows removed from the analyses that had no CL (data not presented).
In conclusion, feeding FM and Ca salts of fish oil fatty acids increased the endometrial content of EPA, DHA, CLA, and total n-3 concentrations and also decreased the n-6:n-3 ratio. These changes in endometrial fatty acid composition did not change PGF2
secretion based on similarity among diets for PGFM concentrations in response to an oxytocin challenge. Additional research is needed to further define tissue fatty acid composition and ratios necessary for inhibitory effects on PGF2
synthesis.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication December 10, 2005. Accepted for publication August 14, 2006.
| REFERENCES |
|---|
|
|
|---|
production by bovine endometrial cells. J. Dairy Sci. 89:971977.
metabolite and milk fatty acid profiles in late lactation Holstein-Friesian cows. Theriogenology 58:14711482.[Medline]
metabolite, and reproductive response in postpartum heifers fed rumen bypass fat. J. Anim. Sci. 78:139144.
in the bovine endometrium. J. Biol. Chem. 278:1120511212.
modify phorbol ester-induced secretion of prostaglandin F2
and expression of prostaglandin endoperoxide synthase-2 and phospholipase-A2 in bovine endometrial cells. Biol. Reprod. 69:780787.
milk composition, and metabolic status of periparturient Holstein cows. J. Dairy Sci. 87:921932.
of cows in response to recombinant interferon-
. J. Dairy Sci. 78:19211931.[Abstract]
in epithelial cells from bovine endometrium. Reproduction 126:539547.[Abstract]
synthesis in beef heifers with low luteal-phase progesterone. J. Anim. Sci. 83:18321838.This article has been cited by other articles:
![]() |
D. L. Palmquist Omega-3 Fatty Acids in Metabolism, Health, and Nutrition and for Modified Animal Product Foods Professional Animal Scientist, June 1, 2009; 25(3): 207 - 249. [Abstract] [PDF] |
||||
![]() |
S. Herath, E. J Williams, S. T Lilly, R. O Gilbert, H. Dobson, C. E Bryant, and I M. Sheldon Ovarian follicular cells have innate immune capabilities that modulate their endocrine function Reproduction, November 1, 2007; 134(5): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. H. Moussavi, R. O. Gilbert, T. R. Overton, D. E. Bauman, and W. R. Butler Effects of Feeding Fish Meal and n-3 Fatty Acids on Milk Yield and Metabolic Responses in Early Lactating Dairy Cows J Dairy Sci, January 1, 2007; 90(1): 136 - 144. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |